Screening Programs
Screening Programs - Related Videos
07:29
Programmed Electrical Stimulation in Mice
0 Views •
Cited by 48 •
2010
Programmed electrical stimulation provides the ability to determine conduction properties of the heart, and the possibility to induce and terminate cardiac arrhythmias using various pacing protocols. Using a transvenous catheter, intracardiac electrogram recordings can be obtained in mice following programmed electrical stimulation protocols to identify arrhythmogenic substrates.
08:10
Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System
0 Views •
Cited by 7 •
2016
This work presents a method of high-throughput screening using a universal genetic enzyme screening system that can be theoretically applied to over 200 enzymes. Here, the single screening system identifies three different enzymes (lipase, cellulase, and alkaline phosphatase) by simply changing the substrate used (p-nitrophenyl acetate, p-nitrophenyl-β-D-cellobioside, and phenyl phosphate).
01:29
Global Marketing Programs
0 Views •
2025
Global marketing strategies play a vital role in how businesses operate in international markets, determining the balance between maintaining brand consistency and adapting to local preferences. Two primary approaches are Standardized Global Marketing and Adapted Global Marketing, each with distinct advantages depending on the business goals and market environment. Standardized global marketing involves using a uniform marketing strategy across all international markets. This includes...
08:15
Temperature-programmed Deoxygenation of Acetic Acid on Molybdenum Carbide Catalysts
0 Views •
Cited by 1 •
2017
Presented here is a protocol for the operation of a micro-scale temperature-programmed reactor for evaluating the catalytic performance of molybdenum carbide during acetic acid deoxygenation.
09:44
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
0 Views •
2015
Here we describe a cell-based reporter gene assay as a valuable tool to screen chemical libraries for compounds modulating post-transcriptional control mechanisms exerted through 3’ UTR.
FAQs
Eligibility criteria establish the population most appropriate for a program, while validated tests or assessments provide a consistent way to identify disease or elevated health risk. The choice must fit the program’s purpose and population. Clear criteria help direct resources toward people who can benefit from timely diagnostic evaluation or follow-up care.
Monitoring benefits and harms keeps a program focused on net value rather than detection alone. Benefit assessment considers whether earlier identification supports prevention, reduces complications, or finds disease at a more treatable stage. Harm monitoring and participation data can reveal problems with testing, communication, follow-up, or access, guiding program improvement.
An abnormal screening result signals that diagnostic evaluation is needed; it does not by itself establish a disease diagnosis. Keeping these stages separate prevents the initial assessment from being treated as a final conclusion and makes referral pathways central to safe clinical care and appropriate follow-up.
After an eligible person participates, the program applies its selected test or assessment and records the result. People with abnormal findings are directed to diagnostic evaluation, followed by appropriate care and follow-up. A dependable workflow also tracks participation and outcomes, helping the program determine whether its process is reaching people and delivering intended health benefits.
Clear communication helps people understand why they are being invited, what the assessment can show, and what an abnormal finding means. Reliable referral pathways then connect participants with diagnostic evaluation and follow-up care. These elements reduce the chance that a person is left without next steps, making implementation as important as test selection.
Screening programs can address cancers, infectious diseases, and inherited conditions, so their design must match the health issue and eligible population. At the individual level, earlier detection may support prevention or reduce complications. At the population level, participation and outcome information can inform public health planning and help determine how well the program performs.